BERLIN (Reuters) -German medical technology firm Brainlab on Tuesday became the latest IPO candidate in the region to put ...

The CEO of German medical technology firm Brainlab said on Tuesday that geopolitical uncertainties had prompted the decision ...

German medical technology company’s decision comes after car parts retailer Autodoc pushes back flotation plans ...

Medical technology company Brainlab postponed its initial public offering in Frankfurt on Tuesday, the latest deal to be shelved as Europe’s market for new listings remains cautious. Munich-based ...

German medical technology firm Brainlab said on Monday it had set the price range for its initial public offering (IPO) at 80 ...

Cirsa’s IPO comprises a €400m primary offering and a €53m secondary offering by LHMC Midco, a holding of Blackstone. Morgan ...

Germany's Brainlab postponed its planned initial public offering indefinitely, dealing another blow to Europe's IPO market.

BERLIN (Reuters) -German medical technology firm Brainlab is expected to price at 80 euros ($93.86) per share in its initial public offering planned for Thursday, according to a statement from a ...

Brainlab, the German medical technology company, set the price range for its forthcoming IPO at €80 to €100 a share on Monday ...

Der Medizinsoftware-Spezialist Brainlab erwägt informierten Kreisen zufolge einen Börsengang in Frankfurt, ... welche Banken für die Begleitung eines IPO infrage kommen.

After the slowest first half for European initial public offerings in more than a decade, dealmakers are banking on several large transactions to reignite the market later this year.

Brainlab had already planned an IPO in 2001, but it was canceled two days before the planned date on July 5. At that time, 5.1 million shares were to be placed at a bookbuilding range of 13.50 to 17 ...